June 23, 2014
Avanir Pharmaceuticals Inc. on Friday filed the latest in a series of suits alleging proposed generic versions of its neurological disorder drug Nuedexta would infringe two of its patents, this time targeting Ranbaxy Laboratories Ltd. in Delaware federal court.